US pharma major Eli Lilly (NYSE: LLY) has partnered with chipmaker NVIDIA (Nasdaq: NVDA) to develop an AI supercomputer for pharmaceutical research, a collaboration that GlobalData says could ...
Biopharma company Pelthos Therapeutics has acquired the US commercialization rights to Xepi (ozenoxacin) Cream, 1%, from ...
The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s Darzalex Faspro (daratumumab and ...
Danish biotech Genmab reported a 25% rise in its total revenue to $1.02 billion during the third quarter of 2025, ahead of ...
German pharma major Bayer announced new Phase III investigational data from the pivotal FINE-ONE trial showing that Kerendia (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) ...
Healthcare giant Johnson & Johnson has announced that the US Food and Drug Administration (FDA) has approved Caplyta ...
US pharma major Eli Lilly has announced an agreement with the US government to expand access to its obesity medicines and reduce patient costs.
The global endometrial cancer market is on course for steady expansion, projected to reach nearly $39 billion by 2030. Growth ...
Danish pharma major Novo Nordisk (NOV: N) has presented new post-hoc analyses from the Phase III REDEFINE 1 trial evaluating ...
Danish diabetes and obesity drug giant Novo Nordisk has agreed with the US Administration to lower drug prices beginning in ...
The USA’s Centers for Medicare & Medicaid Services (CMS) is tackling high drug prices and protecting the American taxpayers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback